Plandai Biotech Stock Price Prediction
As of now the relative strength index (rsi) of Plandai Biotech's share price is below 20 indicating that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Plandai Biotech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Plandai Biotech and does not consider all of the tangible or intangible factors available from Plandai Biotech's fundamental data. We analyze noise-free headlines and recent hype associated with Plandai Biotech, which may create opportunities for some arbitrage if properly timed.
Check out Plandai Biotech Basic Forecasting Models to cross-verify your projections.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Plandai Biotech hype-based prediction, you can estimate the value of Plandai Biotech from the perspective of Plandai Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Plandai Biotech to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Plandai because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Plandai Biotech after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Plandai |
Plandai Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Plandai Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Plandai Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Plandai Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Plandai Biotech Estimiated After-Hype Price Volatility
In the context of predicting Plandai Biotech's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Plandai Biotech's historical news coverage. Plandai Biotech's after-hype downside and upside margins for the prediction period are 0.00 and 50.00, respectively. We have considered Plandai Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Plandai Biotech is out of control at this time. Analysis and calculation of next after-hype price of Plandai Biotech is based on 3 months time horizon.
Plandai Biotech Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Plandai Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Plandai Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Plandai Biotech, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
42.62 | 220.95 | 0.00 | 27.02 | 0 Events / Month | 5 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.00 | 0.00 | 0.00 |
|
Plandai Biotech Hype Timeline
Plandai Biotech is at this time traded for 0.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 27.02. Plandai is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 42.62%. %. The volatility of related hype on Plandai Biotech is about 34850.16%, with the expected price after the next announcement by competition of 27.02. The company recorded a loss per share of 0.03. Plandai Biotech had not issued any dividends in recent years. The entity had 1:2000 split on the 19th of September 2008. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Plandai Biotech Basic Forecasting Models to cross-verify your projections.Plandai Biotech Related Hype Analysis
Having access to credible news sources related to Plandai Biotech's direct competition is more important than ever and may enhance your ability to predict Plandai Biotech's future price movements. Getting to know how Plandai Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Plandai Biotech may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| MRT | Marti Technologies | (0.01) | 8 per month | 2.43 | (0.03) | 7.59 | (4.02) | 20.77 | |
| TIMB | TIM Participacoes SA | (0.03) | 9 per month | 1.90 | 0.03 | 3.06 | (2.72) | 8.26 | |
| CCCC | C4 Therapeutics | 0.36 | 8 per month | 0.00 | (0.03) | 8.16 | (7.32) | 24.93 | |
| HOLO | MicroCloud Hologram | (0.01) | 10 per month | 0.00 | (0.14) | 5.57 | (8.22) | 15.30 | |
| IMMR | Immersion | 0.13 | 12 per month | 2.19 | (0.03) | 4.57 | (3.90) | 22.47 | |
| ABSOF | ABS CBN Holdings | 0.00 | 0 per month | 0.00 | (0.14) | 0.00 | 0.00 | 40.00 | |
| HRZN | Horizon Technology Finance | (0.01) | 8 per month | 0.79 | 0.12 | 2.53 | (1.59) | 11.64 | |
| LLYVK | Liberty Live Holdings | (0.05) | 5 per month | 0.00 | (0.14) | 2.12 | (2.93) | 10.93 | |
| LSIIX | Loomis Sayles Investment | 6.10 | 5 per month | 0.16 | (0.59) | 0.20 | (0.30) | 0.61 | |
| HPQ | HP Inc | (0.14) | 10 per month | 0.00 | (0.27) | 2.73 | (3.97) | 10.78 |
Plandai Biotech Additional Predictive Modules
Most predictive techniques to examine Plandai price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Plandai using various technical indicators. When you analyze Plandai charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Plandai Biotech Predictive Indicators
The successful prediction of Plandai Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Plandai Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Plandai Biotech based on analysis of Plandai Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Plandai Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Plandai Biotech's related companies.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Plandai Pink Sheet
Plandai Biotech financial ratios help investors to determine whether Plandai Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Plandai with respect to the benefits of owning Plandai Biotech security.